Discover a study where patients reported a high severity of treatment side effects than anticipated by their clinicians.

Join leading experts to discuss how we are ushering in a new era in bladder cancer care on May 28 virtually. Register now.

Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 125.3 million in the first quarter of 2025 (Q1 2024: NOK ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

UroGen Pharma ( NASDAQ: URGN) announced on Wednesday that the U.S. FDA has scheduled an Oncologic Drugs Advisory Committee ...

Data on the efficacy of radical prostatectomy in managing clinically node-positive prostate cancer have been limited.

Colorectal cancer is on the rise among young adults. An international research effort led by UC San Diego bioengineers has uncovered that DNA mutations arising during early childhood from a bacterial ...

Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment ...